Literature DB >> 31417799

Crystal structure of tetra-μ-acetato-bis-[(5-amino-2-methyl-sulfanyl-1,3,4-thia-diazole-κN 1)copper(II)].

Batirbay Torambetov1, Shaxnoza Kadirova1, Turdibek Toshmurodov2, Jamshid Mengnorovich Ashurov3, Nusrat Agzamovich Parpiev1, Abdukhakim Ziyaev2.   

Abstract

The reaction of 2-methyl-thio-5-amino-1,3,4-thia-diazole (Me-SNTD; C3H5N3S2) with copper(II) acetate monohydrate [Cu(OAc)2·H2O; C4H8CuO5] resulted in the formation of the title binuclear compound, [Cu2(C2H3O2)4(C3H5N3S2)2] or [Cu2(OAc)4(Me-SNTD)2]. The structure has triclinic (P ) symmetry with a crystallographic inversion centre located at the midpoint of the line connecting the Cu atoms in the dimer. These two Cu atoms of the dimer [CuCu = 2.6727 (6) Å] are held together by four carboxyl-ate groups. Each Cu atom is further coordinated to the N atom of an Me-SNTD mol-ecule and exhibits a Jahn-Teller-distorted octa-hedral geometry. The dimers are connected into infinite chains by hydrogen bonds between the NH (Me-SNTD) and the carboxyl-ate groups of neighbouring mol-ecules, generating an R 2 2(12) ring motif. The mol-ecules are further linked by C-H⋯π inter-actions between the thia-diazole rings and the methyl groups of the acetate units.

Entities:  

Keywords:  copper(II); crystal structure; hydrogen bonding.; thia­diazole

Year:  2019        PMID: 31417799      PMCID: PMC6690473          DOI: 10.1107/S2056989019010272

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

1,3,4-Thia­dazoles are an important class of heterocycles and are of great inter­est because of their broad spectrum of biological activity. 1,3,4-Thia­diazole derivatives and their metal complexes have been shown to display anti­microbial (Önkol et al., 2008 ▸; Abdel-Wahab et al., 2009 ▸; Kadi et al., 2010 ▸), anti­tuberculosis (Karakuşs et al., 2002 ▸; Foroumadi et al., 2004 ▸), anti­oxidant (Chitale et al., 2011 ▸; Sunil et al., 2010 ▸; Khan et al., 2010 ▸), anti­cancer (Padmavathi et al., 2009 ▸; Kumar et al., 2010 ▸;) and anti­fungal (Matysiak et al., 2007 ▸; Klip et al., 2010 ▸; Verma et al., 2011 ▸; Zoumpoulakis et al., 2012 ▸) activities. In addition, some of the 1,3,4-thia­diazole-ring-containing ligands can be efficient uptake agents of toxic metal ions (Mincione et al., 1997 ▸). 1,3,4-Thia­diazo­les also exhibit great potential as pesticides in the fields of herbicides, fungicides, insecticides and even as plant-growth regulators. Their diverse biological activity possibly arises from the presence of the =NCS moiety in the mol­ecule (Oruç et al., 2004 ▸). An inter­esting feature of the metal–ligand chemistry of these compounds is that the complexes can be either mononuclear (Tzeng et al., 2004 ▸; Varna et al., 2018 ▸; Qiu et al., 2014 ▸) or binuclear (Deckert et al., 2016 ▸; Ardan et al., 2017 ▸). A search of the Cambridge Structural Database (CSD Version 5.4, update of February 2019; Groom et al., 2016 ▸) revealed that although crystal structures have been reported for complexes of either 1,3,4-thia­diazole derivatives or OAc with a number of metal ions, including zinc, copper, nickel, manganese, cadmium, cobalt and palladium, no examples are known of mixed-ligand metal complexes containing both 1,3,4-thia­diazole derivatives and OAc. Herein, we report on the synthesis and crystal structure of a new binuclear complex, [Cu2(OAc)4 L 2], with L = 2-methyl­thio-5-amino-1,3,4-thia­diazole (Me-SNTD).

Structural commentary

The title binuclear CuII complex, (I) (Fig. 1 ▸), is arranged about a crystallographic inversion centre located at the midpoint of the CuCu-connecting line. The asymmetric unit comprises one half of the complex mol­ecule, namely, one Cu atom, two acetate groups and one 2-methyl­thio-5-amino-1,3,4-thia­diazole mol­ecule. The two Cu atoms in the dimer are held together by the four carboxyl­ate groups. Each Cu atom is bound in a square-pyramidal configuration to four carboxyl­ate O atoms and to the N atom of an Me-SNTD mol­ecule.
Figure 1

The mol­ecular structure of [Cu2(OAc)4(Me-SNTD)2] with the atom-numbering scheme. Displacement ellipsoids are drawn at the 25% probability level. Intra­molecular hydrogen bonds are shown as dashed lines. Atoms labelled with the suffix A are generated by the symmetry operation 2 − x, 1 − y, 1 − z.

Each copper atom is displaced by 0.754 (3) Å from the plane defined by basal-plane atoms O1, O2, O3 and O4 towards the nitro­gen atom, N2. The Cu1A —Cu1—N2 angle is 177.95 (7)° [symmetry code: (A) 2 − x, 1 − y, 1 - z]. The Cu—O bond lengths range from 1.962 (2) to 2.001 (2) Å and the Cu—N distance is 2.180 (3) Å. The CuCu distance is 2.6727 (6) Å and each metal atom exhibits a Jahn–Teller-distorted octa­hedral geometry. The observed CuO2 bond length of 1.983 (2) Å is longer than the Cu—O1 distance of 1.962 (2) Å. The elongation of this Cu—O distance may be due to the intra­molecular N3—H⋯O2 hydrogen bond (Table 1 ▸). The conformation of the ligand is approximately planar, with a maximum deviation from the least-squares plane of 0.066 (2) Å for atom N3. The thia­diazole ring is planar (r.m.s. deviation 0.0063 Å). The dihedral angle between the planes of the two independent acetate groups is 82.646 (14)°. The thia­diazole ring is twisted by 18.37 (2)° with respect to the acetate (C4/C5/O1/O2) ligand mean plane.
Table 1

Hydrogen-bond geometry (Å, °)

Cg is the centroid of the S1/N1/N2/C1/C2 ring.

D—H⋯A D—HH⋯A DA D—H⋯A
N3—H3A⋯O4i 0.86 (1)2.16 (2)2.963 (4)156 (4)
N3—H3B⋯O2ii 0.86 (1)2.11 (3)2.884 (4)150 (4)

Symmetry codes: (i) ; (ii) .

Supra­molecular features

The packing of (I) is shown in Fig. 2 ▸. The acetate group containing oxygen atoms O1 and O3 does not form any hydrogen bonds. However, the acetate group containing oxygen atoms O2 and O4 forms both intra- and inter­molecular hydrogen bonds. Each binuclear complex mol­ecule exhibits one intra­molecular N3—H3⋯O2i hydrogen bond, forming a six-membered ring. The dimers are connected through an inter­molecular N3—H3⋯O4ii hydrogen bond between the NH (Me-SNTD) and the carboxyl­ate groups, forming chains propagating parallel to [001]. The above-mentioned hydrogen bonds give rise to (12), (14) and (6) graph-set motifs (Table 1 ▸ and Fig. 2 ▸). Additional C—H⋯π inter­actions between the thia­diazole rings and the acetate methyl groups generate a three-dimensional supra­molecular framework (Fig. 3 ▸).
Figure 2

Part of the crystal structure with hydrogen bonds shown as dashed lines. For clarity, H atoms not involved in hydrogen bonding are omitted.

Figure 3

Packing of the structural units in (I). Hydrogen bonds are indicated by blue dashed lines and C—H⋯π inter­actions by black dashed lines.

Database survey

A survey of the Cambridge Structural Database (CSD Version 5.4, update of February 2019; Groom et al., 2016 ▸) revealed that crystal structures have been reported for complexes of 1,3,4-thia­diazole derivatives and OAc with a number of metal ions, including zinc, copper, nickel, manganese, cadmium, cobalt and palladium. Copper(II) acetate complexes of the general formula [Cu2(OAc)4 L 2], where L is a ligand with an oxygen or nitro­gen ligator atom, have been well explored. The structures of 2-methyl­thio-5-amino-1,3,4-thia­diazole and a complex of this mol­ecule with cadmium have been deposited in the CSD [XUVPEK (Lynch, 2010 ▸) and JIZKEK (Soudani et al., 2014 ▸), respectively]. However, no mixed-ligand metal complexes containing both 1,3,4-thia­diazole derivatives and OAc have been documented in the CSD.

Synthesis and crystallization

Cu(OAc)2·H2O (0.218 g, 1 mmol) and 2-methyl­thio-5-amino-1,3,4-thia­diazole (0.147 g, 1 mmol) were dissolved separately in a mixture of methanol-di­chloro­methane (10 mL, 1:1 v/v), mixed together and stirred for 1.5 h. The green solid that precipitated was dissolved in methanol to form a green solution. Single crystals of the complex suitable for X-ray analysis were obtained by slow evaporation of the solution over a period of 10 d.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The restraint N—H = 0.86 ± (1) Å was applied. Methyl H atoms were positioned geometrically C—H = 0.96) and refined as riding with U iso(H) = 1.5Ueq(C).
Table 2

Experimental details

Crystal data
Chemical formula[Cu2(C2H3O2)4(C3H5N3S2)2]
M r 657.69
Crystal system, space groupTriclinic, P
Temperature (K)571
a, b, c (Å)8.1069 (4), 8.8955 (4), 9.0421 (5)
α, β, γ (°)100.656 (4), 98.966 (4), 97.643 (4)
V3)624.14 (5)
Z 1
Radiation typeCu Kα
μ (mm−1)5.70
Crystal size (mm)0.44 × 0.38 × 0.28
 
Data collection
DiffractometerRigaku Oxford Diffraction Xcalibur, Ruby
Absorption correctionMulti-scan (CrysAlis PRO; Rigaku OD, 2018)
T min, T max 0.083, 1.000
No. of measured, independent and observed [I > 2σ(I)] reflections11239, 2582, 2244
R int 0.052
(sin θ/λ)max−1)0.630
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.040, 0.118, 1.07
No. of reflections2582
No. of parameters165
No. of restraints2
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3)0.47, −0.44

Computer programs: CrysAlis PRO (Rigaku OD, 2018 ▸), SHELXL (Sheldrick, 2015 ▸) and OLEX2 (Dolomanov et al., 2009 ▸).

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989019010272/cq2032sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989019010272/cq2032Isup2.hkl CCDC reference: 1941461 Additional supporting information: crystallographic information; 3D view; checkCIF report
[Cu2(C2H3O2)4(C3H5N3S2)2]Z = 1
Mr = 657.69F(000) = 334
Triclinic, P1Dx = 1.750 Mg m3
a = 8.1069 (4) ÅCu Kα radiation, λ = 1.54184 Å
b = 8.8955 (4) ÅCell parameters from 5762 reflections
c = 9.0421 (5) Åθ = 5.0–75.8°
α = 100.656 (4)°µ = 5.70 mm1
β = 98.966 (4)°T = 571 K
γ = 97.643 (4)°Block, blue
V = 624.14 (5) Å30.44 × 0.38 × 0.28 mm
Rigaku Oxford Diffraction Xcalibur, Ruby diffractometer2582 independent reflections
Radiation source: fine-focus sealed X-ray tube, Enhance (Cu) X-ray Source2244 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.052
Detector resolution: 10.2576 pixels mm-1θmax = 76.2°, θmin = 5.1°
ω scansh = −10→10
Absorption correction: multi-scan (CrysAlisPro; Rigaku OD, 2018)k = −11→11
Tmin = 0.083, Tmax = 1.000l = −10→11
11239 measured reflections
Refinement on F22 restraints
Least-squares matrix: fullHydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.040H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.118w = 1/[σ2(Fo2) + (0.0726P)2 + 0.1915P] where P = (Fo2 + 2Fc2)/3
S = 1.07(Δ/σ)max = 0.001
2582 reflectionsΔρmax = 0.47 e Å3
165 parametersΔρmin = −0.44 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
xyzUiso*/Ueq
Cu10.94133 (5)0.41682 (4)0.59528 (5)0.03080 (16)
S10.77895 (10)0.21114 (9)1.00281 (9)0.0416 (2)
S20.42143 (12)0.08505 (14)0.83586 (12)0.0659 (3)
O41.0956 (3)0.3780 (2)0.2926 (2)0.0403 (5)
O20.8200 (3)0.5370 (3)0.2953 (3)0.0409 (5)
O10.7249 (3)0.3994 (3)0.4563 (3)0.0458 (5)
O31.0032 (3)0.2430 (2)0.4575 (3)0.0438 (5)
N31.0840 (4)0.3406 (3)0.9585 (3)0.0442 (6)
N20.8489 (3)0.2883 (3)0.7575 (3)0.0354 (5)
N10.6790 (3)0.2193 (3)0.7215 (3)0.0385 (6)
C10.9196 (4)0.2903 (3)0.8988 (3)0.0327 (6)
C61.0679 (4)0.2556 (3)0.3428 (3)0.0363 (6)
C40.7032 (4)0.4586 (3)0.3410 (4)0.0367 (6)
C20.6271 (4)0.1756 (3)0.8362 (4)0.0383 (6)
C71.1194 (5)0.1119 (4)0.2574 (5)0.0567 (9)
H7A1.1068500.1142810.1505850.085*
H7B1.0486570.0214730.2701160.085*
H7C1.2354950.1087160.2973390.085*
C50.5263 (4)0.4374 (5)0.2518 (5)0.0565 (9)
H5A0.4590750.4956340.3116490.085*
H5B0.4773580.3294100.2282700.085*
H5C0.5292610.4734770.1583890.085*
C30.3241 (6)0.0719 (6)0.6412 (5)0.0740 (13)
H3C0.3737410.0011720.5747240.111*
H3D0.3415040.1725150.6163650.111*
H3E0.2048710.0349890.6279430.111*
H3A1.119 (5)0.357 (4)1.0554 (14)0.048 (10)*
H3B1.149 (5)0.377 (5)0.903 (5)0.070 (13)*
U11U22U33U12U13U23
Cu10.0315 (2)0.0301 (2)0.0309 (3)0.00161 (15)0.00874 (17)0.00645 (16)
S10.0421 (4)0.0494 (4)0.0336 (4)−0.0010 (3)0.0112 (3)0.0114 (3)
S20.0408 (5)0.0941 (7)0.0623 (6)−0.0141 (5)0.0082 (4)0.0347 (6)
O40.0516 (13)0.0353 (10)0.0367 (12)0.0105 (9)0.0164 (10)0.0054 (9)
O20.0312 (10)0.0497 (11)0.0409 (12)0.0015 (9)0.0043 (9)0.0130 (10)
O10.0333 (11)0.0572 (13)0.0450 (13)−0.0018 (9)0.0039 (9)0.0154 (11)
O30.0599 (14)0.0309 (9)0.0423 (13)0.0072 (9)0.0171 (11)0.0056 (9)
N30.0374 (14)0.0580 (16)0.0353 (16)−0.0021 (11)0.0051 (12)0.0132 (13)
N20.0371 (13)0.0357 (11)0.0334 (13)−0.0002 (9)0.0077 (10)0.0106 (10)
N10.0375 (13)0.0409 (12)0.0373 (14)−0.0007 (10)0.0072 (11)0.0138 (10)
C10.0377 (14)0.0286 (11)0.0339 (15)0.0037 (10)0.0127 (12)0.0081 (11)
C60.0389 (15)0.0318 (13)0.0352 (16)0.0085 (11)0.0027 (12)0.0006 (11)
C40.0294 (13)0.0399 (14)0.0369 (17)0.0024 (11)0.0060 (12)0.0004 (12)
C20.0365 (15)0.0382 (14)0.0408 (17)0.0001 (11)0.0084 (13)0.0130 (12)
C70.077 (3)0.0424 (17)0.056 (2)0.0278 (17)0.0212 (19)0.0030 (15)
C50.0329 (16)0.075 (2)0.059 (2)0.0039 (15)0.0028 (16)0.0144 (19)
C30.053 (2)0.093 (3)0.067 (3)−0.015 (2)−0.004 (2)0.024 (2)
Cu1—Cu1i2.6728 (8)N3—H3B0.856 (10)
Cu1—O4i2.0007 (19)N2—N11.394 (3)
Cu1—O2i1.983 (2)N2—C11.313 (4)
Cu1—O11.962 (2)N1—C21.282 (4)
Cu1—O31.970 (2)C6—C71.510 (4)
Cu1—N22.180 (2)C4—C51.502 (4)
S1—C11.745 (3)C7—H7A0.9600
S1—C21.740 (3)C7—H7B0.9600
S2—C21.752 (3)C7—H7C0.9600
S2—C31.789 (5)C5—H5A0.9600
O4—C61.262 (4)C5—H5B0.9600
O2—C41.267 (4)C5—H5C0.9600
O1—C41.251 (4)C3—H3C0.9600
O3—C61.249 (4)C3—H3D0.9600
N3—C11.339 (4)C3—H3E0.9600
N3—H3A0.857 (10)
O4i—Cu1—Cu1i83.88 (6)N2—C1—S1113.1 (2)
O4i—Cu1—N294.39 (9)N2—C1—N3124.8 (3)
O2i—Cu1—Cu1i84.10 (7)O4—C6—C7117.0 (3)
O2i—Cu1—O4i89.30 (9)O3—C6—O4125.8 (3)
O2i—Cu1—N294.80 (9)O3—C6—C7117.2 (3)
O1—Cu1—Cu1i82.97 (7)O2—C4—C5117.6 (3)
O1—Cu1—O4i89.12 (10)O1—C4—O2124.5 (3)
O1—Cu1—O2i167.07 (9)O1—C4—C5117.8 (3)
O1—Cu1—O390.92 (10)S1—C2—S2119.34 (18)
O1—Cu1—N298.11 (10)N1—C2—S1115.2 (2)
O3—Cu1—Cu1i83.44 (7)N1—C2—S2125.5 (3)
O3—Cu1—O4i167.22 (9)C6—C7—H7A109.5
O3—Cu1—O2i87.81 (10)C6—C7—H7B109.5
O3—Cu1—N298.26 (9)C6—C7—H7C109.5
N2—Cu1—Cu1i177.95 (7)H7A—C7—H7B109.5
C2—S1—C186.58 (14)H7A—C7—H7C109.5
C2—S2—C3100.75 (18)H7B—C7—H7C109.5
C6—O4—Cu1i122.12 (19)C4—C5—H5A109.5
C4—O2—Cu1i122.8 (2)C4—C5—H5B109.5
C4—O1—Cu1125.6 (2)C4—C5—H5C109.5
C6—O3—Cu1124.56 (19)H5A—C5—H5B109.5
C1—N3—H3A121 (3)H5A—C5—H5C109.5
C1—N3—H3B119 (3)H5B—C5—H5C109.5
H3A—N3—H3B119 (4)S2—C3—H3C109.5
N1—N2—Cu1116.61 (18)S2—C3—H3D109.5
C1—N2—Cu1128.89 (19)S2—C3—H3E109.5
C1—N2—N1113.1 (2)H3C—C3—H3D109.5
C2—N1—N2112.1 (3)H3C—C3—H3E109.5
N3—C1—S1122.1 (2)H3D—C3—H3E109.5
D—H···AD—HH···AD···AD—H···A
N3—H3A···O4ii0.86 (1)2.16 (2)2.963 (4)156 (4)
N3—H3B···O2i0.86 (1)2.11 (3)2.884 (4)150 (4)
C7—H7B···Cgiii0.963.003.346 (4)103
  13 in total

1.  1,3,4-thiadiazole derivatives. Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation.

Authors:  Elçin E Oruç; Sevim Rollas; Fatma Kandemirli; Nathaly Shvets; Anatholy S Dimoglo
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

2.  Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles.

Authors:  V Padmavathi; G Sudhakar Reddy; A Padmaja; P Kondaiah
Journal:  Eur J Med Chem       Date:  2008-11-01       Impact factor: 6.514

3.  Synthesis, structure, and antifungal evaluation of some novel 1,2,4-triazolylmercaptoacetylthiosemicarbazide and 1,2,4-triazolylmercaptomethyl-1,3,4-thiadiazole analogs.

Authors:  Nalan Terzioğlu Klip; Gültaze Capan; Aysel Gürsoy; Meltem Uzun; Dilek Satana
Journal:  J Enzyme Inhib Med Chem       Date:  2010-02       Impact factor: 5.051

4.  Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.

Authors:  Adnan A Kadi; Ebtehal S Al-Abdullah; Ihsan A Shehata; Elsayed E Habib; Tarek M Ibrahim; Ali A El-Emam
Journal:  Eur J Med Chem       Date:  2010-08-12       Impact factor: 6.514

5.  Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives.

Authors:  Imtiaz Khan; Sajid Ali; Shahid Hameed; Nasim Hasan Rama; Muhammad Tahir Hussain; Abdul Wadood; Reaz Uddin; Zaheer Ul-Haq; Ajmal Khan; Sajjad Ali; M Iqbal Choudhary
Journal:  Eur J Med Chem       Date:  2010-08-18       Impact factor: 6.514

6.  Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.

Authors:  Dalip Kumar; N Maruthi Kumar; Kuei-Hua Chang; Kavita Shah
Journal:  Eur J Med Chem       Date:  2010-07-21       Impact factor: 6.514

7.  Synthesis and antituberculosis activity of new N-phenyl-N'-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas.

Authors:  S Karakuş; S Rollas
Journal:  Farmaco       Date:  2002-07

8.  Synthesis and antimicrobial activity of new 1,2,4-triazole and 1,3,4-thiadiazole derivatives.

Authors:  Tijen Onkol; Deniz S Doğruer; Leyla Uzun; Selcen Adak; Semiha Ozkan; M Fethi Sahin
Journal:  J Enzyme Inhib Med Chem       Date:  2008-04       Impact factor: 5.051

9.  Antituberculosis agents X. Synthesis and evaluation of in vitro antituberculosis activity of 2-(5-nitro-2-furyl)- and 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole derivatives.

Authors:  Alireza Foroumadi; Fatemeh Soltani; Raheleh Jabini; Mohammad Hasan Moshafi; Fatemeh Mohammadian Rasnani
Journal:  Arch Pharm Res       Date:  2004-05       Impact factor: 4.946

10.  Carbonic Anhydrase Inhibitors. Part 46 Inhibition of Carbonic Anhydrase Isozymes I, II and IV With Trifluoromethylsulfonamide Derivatives and Their Zinc(II) and Copper(II) Complexes.

Authors:  G Mincione; A Scozzafava; C T Supuran
Journal:  Met Based Drugs       Date:  1997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.